Ho Maykin
SEC CIK 1646395 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Dir | 19.8K | — | — | 5 | 2022-05-20 | 2026-06-18 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Dir | 35.5K | — | — | 5 | 2022-05-24 | 2026-06-02 |
| NMRA | Neumora Therapeutics, Inc. | Dir | 20.1K | — | — | 1 | 2024-06-13 | 2024-06-13 |
| KYNB | KYNTRA BIO, INC. | Dir | 37.7K | — | $148.6K | 3 | 2022-06-16 | 2023-06-08 |
Most active insiders at AGIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Goff Brian | CEO, Dir | — | $1.69M |
| 2 | Gheuens Sarah | Chief Medical Off | — | $1.63M |
| 3 | Jones Cecilia | CFO | — | $468.5K |
| 4 | Milanova Tsveta | Chief Commercial Off | — | $353.3K |
| 5 | Burns James William | CLO | — | $344.4K |
| 6 | Washburn Theodore James Jr. | Principal Accounting Off | — | $216.6K |
| 7 | Viswanadhan Krishnan | Chief Corp Dev, Strategy | — | $185.0K |
| 8 | Scadden David | Dir | — | $25.0K |
| 9 | Owen Adams Catherine | Dir | — | — |
| 10 | Ballal Rahul D. | Dir | — | — |
| 12 | Ho Maykin | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:21 | 2026-06-18 | AGIO | AGIOS PHARMACEUTICALS, INC. | Ho Maykin | Dir | M - OptEx | $0.00 | +2,816 | 19.8K | +17% | $0 |
| 2026-06-04 18:07 | 2026-06-02 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ho Maykin | Dir | A - Grant | $0.00 | +7,490 | 35.5K | +27% | $0 | |
| D | 2025-06-23 | 2025-06-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Ho Maykin | Dir | M - OptEx | $0.00 | +2,120 | 17.0K | +14% | $0 |
| 2025-05-22 | 2025-05-20 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ho Maykin | Dir | A - Grant | $0.00 | +6,650 | 28.0K | +31% | $0 | |
| D | 2024-06-17 | 2024-06-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Ho Maykin | Dir | M - OptEx | $0.00 | +3,388 | 14.9K | +29% | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Neumora Therapeutics, Inc. | Ho Maykin | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| 2024-05-23 | 2024-05-21 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ho Maykin | Dir | A - Grant | $0.00 | +4,720 | 21.4K | +28% | $0 | |
| D | 2023-06-23 | 2023-06-21 | AGIO | AGIOS PHARMACEUTICALS, INC. | Ho Maykin | Dir | M - OptEx | $0.00 | +4,975 | 11.5K | +76% | $0 |
| DM | 2023-06-09 | 2023-06-08 | KYNB | KYNTRA BIO, INC. | Ho Maykin | Dir | S - Sale | $17.44 | -8,520 | 37.7K | -18% | -$148.6K |
| D | 2023-06-09 | 2023-06-07 | KYNB | KYNTRA BIO, INC. | Ho Maykin | Dir | A - Grant | $0.00 | +8,289 | 40.0K | +26% | $0 |
| 2023-05-24 | 2023-05-23 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ho Maykin | Dir | A - Grant | $0.00 | +4,190 | 16.6K | +34% | $0 | |
| D | 2022-06-21 | 2022-06-16 | KYNB | KYNTRA BIO, INC. | Ho Maykin | Dir | A - Grant | $0.00 | +15.8K | 31.7K | +99% | $0 |
| 2022-05-26 | 2022-05-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ho Maykin | Dir | A - Grant | $0.00 | +4,980 | 12.4K | +67% | $0 | |
| D | 2022-05-24 | 2022-05-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Ho Maykin | Dir | M - OptEx | $0.00 | +1,585 | 6,549 | +32% | $0 |
Purchase Sale Sale after option exercise All abbreviations